The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANTERIX INC COMMON | CMN | 03676C100 | 24,921 | 741,482 | SH | SOLE | 741,482 | 0 | 0 | ||
INNOVATE CORP COMMON | CMN | 45784J105 | 1,025 | 1,463,068 | SH | SOLE | 1,463,068 | 0 | 0 | ||
IRSA INVERSIONES SA WTS EXP 03/25/2026 | CMN | P5880C134 | 409 | 602,130 | SH | SOLE | 602,130 | 0 | 0 | ||
JOYY INC ADR | CMN | 46591M109 | 14,901 | 484,587 | SH | SOLE | 484,587 | 0 | 0 | ||
NEXTPOINT DIVERSIFIED REAL ESTATE CLOSED-END FUND | CMN | 65340G205 | 2,789 | 422,602 | SH | SOLE | 422,602 | 0 | 0 | ||
TRINITY BIOTECH PLC ADR | CMN | 896438504 | 507 | 248,399 | SH | SOLE | 248,399 | 0 | 0 |